palinavir has been researched along with valine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, PC; Bourgon, L; Clouette, C; Cohen, E; Croteau, G; Lamarre, D; Pargellis, C; Thibeault, D; Vaillancourt, M; Wardrop, E; Yoakim, C | 1 |
| Jaramillo, J; Liard, F; Paris, WL; Yoakim, C | 1 |
| Darlix, JL; Décimo, D; Garin, J; Morley, SJ; Ohlmann, T; Prévôt, D; Roux, F | 1 |
3 other study(ies) available for palinavir and valine
| Article | Year |
|---|---|
Antiviral properties of palinavir, a potent inhibitor of the human immunodeficiency virus type 1 protease.
Topics: Anti-HIV Agents; Drug Combinations; Drug Evaluation, Preclinical; HIV Protease Inhibitors; HIV-1; HIV-2; Humans; Nevirapine; Pyridines; Quinolines; Reverse Transcriptase Inhibitors; Simian Immunodeficiency Virus; Valine; Virus Replication | 1997 |
Pharmacokinetic aspects of palinavir, an HIV protease inhibitor, in Sprague-Dawley rats.
Topics: Animals; Anti-HIV Agents; Biological Availability; HIV Protease Inhibitors; Quinolines; Rats; Rats, Sprague-Dawley; Valine | 1998 |
In vitro cleavage of eIF4GI but not eIF4GII by HIV-1 protease and its effects on translation in the rabbit reticulocyte lysate system.
Topics: Amino Acid Sequence; Animals; Cell Line; Eukaryotic Initiation Factor-4G; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; In Vitro Techniques; Leukemia; Peptide Fragments; Peptide Initiation Factors; Protein Biosynthesis; Quinolines; Rabbits; Recombinant Proteins; Reticulocytes; Ribosomes; Sequence Analysis, Protein; Substrate Specificity; Valine | 2002 |